769 related articles for article (PubMed ID: 25817337)
1. Delivery strategies to enhance oral vaccination against enteric infections.
Davitt CJ; Lavelle EC
Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337
[TBL] [Abstract][Full Text] [Related]
2. Mucosal immunity: implications for vaccine development.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Immunobiology; 1992 Feb; 184(2-3):157-79. PubMed ID: 1587541
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunity and vaccination.
Holmgren J
FEMS Microbiol Immunol; 1991 Dec; 4(1):1-9. PubMed ID: 1815705
[TBL] [Abstract][Full Text] [Related]
4. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
De Magistris MT
Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
[TBL] [Abstract][Full Text] [Related]
5. Novel vaccine development strategies for inducing mucosal immunity.
Fujkuyama Y; Tokuhara D; Kataoka K; Gilbert RS; McGhee JR; Yuki Y; Kiyono H; Fujihashi K
Expert Rev Vaccines; 2012 Mar; 11(3):367-79. PubMed ID: 22380827
[TBL] [Abstract][Full Text] [Related]
6. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
[TBL] [Abstract][Full Text] [Related]
7. A novel adjuvanted capsule based strategy for oral vaccination against infectious diarrhoeal pathogens.
Davitt CJ; McNeela EA; Longet S; Tobias J; Aversa V; McEntee CP; Rosa M; Coulter IS; Holmgren J; Lavelle EC
J Control Release; 2016 Jul; 233():162-73. PubMed ID: 27157995
[TBL] [Abstract][Full Text] [Related]
8. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology solutions for mucosal immunization.
Chadwick S; Kriegel C; Amiji M
Adv Drug Deliv Rev; 2010 Mar; 62(4-5):394-407. PubMed ID: 19931581
[TBL] [Abstract][Full Text] [Related]
10. Bacterial enteric infections and vaccine development.
Holmgren J; Svennerholm AM
Gastroenterol Clin North Am; 1992 Jun; 21(2):283-302. PubMed ID: 1512046
[TBL] [Abstract][Full Text] [Related]
11. Induction of secretory immunity and memory at mucosal surfaces.
Brandtzaeg P
Vaccine; 2007 Jul; 25(30):5467-84. PubMed ID: 17227687
[TBL] [Abstract][Full Text] [Related]
12. New insights in mucosal vaccine development.
Pavot V; Rochereau N; Genin C; Verrier B; Paul S
Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
[TBL] [Abstract][Full Text] [Related]
13. Novel vaccination strategies for the control of mucosal infection.
Husband AJ
Vaccine; 1993; 11(2):107-12. PubMed ID: 8438609
[TBL] [Abstract][Full Text] [Related]
14. Nasal and pulmonary vaccine delivery using particulate carriers.
Jia Y; Krishnan L; Omri A
Expert Opin Drug Deliv; 2015 Jun; 12(6):993-1008. PubMed ID: 25952104
[TBL] [Abstract][Full Text] [Related]
15. Strategies for mucosal vaccine development.
Boyaka PN; Marinaro M; Vancott JL; Takahashi I; Fujihashi K; Yamamoto M; van Ginkel FW; Jackson RJ; Kiyono H; McGhee JR
Am J Trop Med Hyg; 1999 Apr; 60(4 Suppl):35-45. PubMed ID: 10344675
[TBL] [Abstract][Full Text] [Related]
16. Mucosal immunisation: adjuvants and delivery systems.
Moyle PM; McGeary RP; Blanchfield JT; Toth I
Curr Drug Deliv; 2004 Oct; 1(4):385-96. PubMed ID: 16305400
[TBL] [Abstract][Full Text] [Related]
17. Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.
Boyaka PN
J Immunol; 2017 Jul; 199(1):9-16. PubMed ID: 28630108
[TBL] [Abstract][Full Text] [Related]
18. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity.
Lawson LB; Norton EB; Clements JD
Curr Opin Immunol; 2011 Jun; 23(3):414-20. PubMed ID: 21511452
[TBL] [Abstract][Full Text] [Related]
19. Mucosal immunization: a review of strategies and challenges.
Patel H; Yewale C; Rathi MN; Misra A
Crit Rev Ther Drug Carrier Syst; 2014; 31(4):273-303. PubMed ID: 25072196
[TBL] [Abstract][Full Text] [Related]
20. Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
Mann JF; Acevedo R; Campo JD; Pérez O; Ferro VA
Expert Rev Vaccines; 2009 Jan; 8(1):103-12. PubMed ID: 19093777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
